Acquisition - August 5, 2014
Roche to buy Santaris Pharma
Swiss Roche has announced that the company has agreed to acquire Danish biopharmaceutical firm Santaris Pharma for USD 450 million. The plan is to expand discovery and development of RNA-targeting medicines. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics, according to Roche which […]
Clinical Trials - August 5, 2014
Sweden invests in Gothenburg center for clinical trials
The Swedish government will initiate a million investment in a center for clinical trials, based in Gothenburg. This was announced by the Minister for Education, Jan Björklund, during his summer speech on August 3. The aim with the investment is to strengthen the co-ordination between the pharmaceutical industry, hospitals and universitites as new medicines are […]
Drug Development Pharma - August 5, 2014
EMA looks to stimulate better use of genomic data in medicines development
The agency is taking a look at better use of genomic data and biomarkers in medicines development and safety monitoring. The European Medicines Agency has released a draft concept paper for public consultation outlining the key elements that will be developed in a guideline on good genomics biomarker practices. The concept paper proposes a framework for the generation […]
Drug Development Pharma - August 4, 2014
Medivir licenses respiratory syncytial virus drug program
The company has entered a license agreement with Boehringer Ingelheim International GmbH for exclusive, global rights to a drug program for the treatment and prevention of RSV infection. The program includes novel compounds that inhibit the RSV fusion protein, which is a key mediator of viral entry into host cells and a target for new […]
MedTech Business - August 1, 2014
MedicPen develops medical management on Bornholm
The Swedish company has entered an agreement to participate in the development of medical management on Bornholm. It will be an online system that according to MedicPen will move the medical management several steps forward. “We are seeing a greater interest in products that help healthcare to increase quality and this is another example of […]
Acquisition - July 31, 2014
Meda acquires Rottapharm
Meda has entered into a definitive agreement to acquire Italian firm Rottapharm for a consideration of SEK 21.2 billion. The consideration will comprise SEK 15.3 billion (€1.643 billion) in cash, 30 million Meda shares corresponding to a value of SEK 3.3 billion (€357 million) and a non-contingent deferred payment in January 2017 of SEK 2.6 billion […]
